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Background: Long non-coding RNAs (lncRNAs) have different functions in cells. They work as signals, decoys,
guides, and scaffolds. Altered lncRNA levels can affect the expression of gene products. There are seldom studies
on the role of lncRNAs in inflammatory bowel disease (IBD).
Results: Quantitative RT-PCR showed that DQ786243 was significantly overexpressed in clinical active CD patients
compared with clinical inactive CD patients (P = 0.0118) or healthy controls (P = 0.002). CREB was also more highly
expressed in active CD than in inactive CD (P = 0.0034) or controls (P = 0.0241). Foxp3 was interestingly lower in
inactive CD than in active CD (P = 0.0317) or controls (P = 0.0103), but there were no apparent differences between
active CD and controls. CRP was well correlated with DQ786243 (r = 0.489, P = 0.034), CREB (r = 0.500, P = 0.029) and
Foxp3 (r = 0.546, P = 0.016). At 48 hours after DQ786243 transfection, qRT-PCR showed both CREB (P = 0.017) and
Foxp3 (P = 0.046) had an increased mRNA expression in Jurkat cells. Western blot showed the same pattern. After
DQ786243 transfection, CREB phosphorylation ratio (p-CREB/t-CREB) was increased (P = 0.0043).
Conclusion: DQ786243 can be related with severity of CD. It can affect the expression of CREB and Foxp3 through
which regulates the function of Treg. CREB itself seems not the mediator of DQ786243 to up-regulate Foxp3. The
phosphorylation of CREB might play a more important role in the process.Background
Long non-coding RNAs (lncRNAs) are non-protein cod-
ing transcripts over 200 bases in length. In functional gen-
omics, they belong to a new type of regulatory genes.
Compared with micro-RNAs (mi-RNAs) [1], their charac-
teristics are much less known. More and more evidences
show that lncRNAs play critical roles in cells, including
stem cell development, pluripotency, cell growth and
apoptosis, etc. [2-6]. LncRNAs regulate protein coding
gene at the level of chromatin remodeling, transcriptional
control and post-transcriptional processing [7]. They work
as signals, decoys, guides, and scaffolds [8]. They may
“sponge” mi-RNAs to regulate the gene expression [9].
Many researches showed altered lncRNA levels could
affect the expression of gene products. Implication of
lncRNAs has been found in nervous system diseases* Correspondence: zhihuaran@vip.126.com; shenjun@vip.163.com
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reproduction in any medium, provided the or[10,11]. LncRNAs also play critical roles in cancer biology
[12,13]. However, there are seldom studies on the role of
lncRNAs in inflammatory bowel disease (IBD).
LncRNA DQ786243 (mentioned as DQ786243 there-
after) is a new lncRNA, which has been found overex-
pressed in hepatocellular carcinoma (HCC) [14]. The
function of DQ786243 is not fully understood. In our pre-
liminary work, we analyzed a small amount of lncRNA ex-
pression microarrays in Crohn’s disease (CD) patients and
healthy controls. Results accidentally showed that the ex-
pression of DQ786243 was closely related with the expres-
sion of cAMP response element binding protein (CREB),
which is important for the activity of the TCR response
element in the forkhead box P3 (Foxp3) [15], a master
transcription factor in function and development of regu-
latory T cells (Treg) [16].
As a type of IBD, the etiology of CD has not been fully
understood. An aberrant immune response to intestinal
microflora might contribute to the disease [17]. Regula-
tory T lymphocytes (Tregs), defined as CD4 positive,
Foxp3 expression T cells [18], are thought to keep bal-
ance in immunity and limit the inflammation. CD25d. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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until Foxp3 was found. Foxp3 was discovered as a “mas-
ter control gene” for CD4+ Treg development and func-
tional maturation [19,20]. FOX proteins are members of
forkhead/winged-helix family which work as transcrip-
tional regulators and may have similar DNA binding in-
teractions in transcription process. Mutations of Foxp3
in human being can lead to severe condition, which is
called IPEX (immune dysregulation, polyendocrinopathy,
enteropathy, X-linked syndrome) [21]. Defects of Tregs
could be an important pathogenesis of CD [22]. It might
implicate the severity of the disease. In this study, we try
to figure out the relationship between DQ786243 and
Treg related genes expression in CD.
Methods
Patients and samples
19 CD patients and 9 healthy controls were enrolled in
this study. Among these 19 patients, 11 of them were
clinical active and 8 of them were clinical inactive (See
Table 1). The diagnoses were confirmed based on clin-
ical endoscopic, pathological and serological examina-
tions by three gastroenterologists. Pregnant patients and
patients with other chronic diseases or cancer were not
included. The activity assessment of the disease was based
on Harvey-Bradshaw Index (HBI) [23]. Total score < 5
stands for clinical inactive disease, ≥ 5 stands for clinical
active disease. Montreal classification were also used in es-
timation of disease characteristics [24]. Healthy blood do-
nors were healthy physicians and postgraduate students
from Renji Hospital. Whole blood samples of donors were
collected in EDTA anti-coagulated vacutainer tubes and
Ficoll density gradient (Sigma Aldrich, St. Louis, MO,Table 1 Characteristic of patients with inflammatory bowel d
Active CD (n = 11) I
Age (yrs) 31.27 ± 8.98













*One way ANOVA; **Montreal classification of extent and behavior of CD.
CD = Crohn’s Disease; CTL = control.USA) was used in isolating peripheral blood mononuclear
cells (PBMCs) from whole blood. Samples of PBMC were
stored in RNA Later (Qiagen, Hilden, Germany) in -80°C
followed the manufacturer’s instructions. All donors were
well informed and the process were approved by Ethics
Committee of Renji Hospital, School of Medicine, Shang-
hai Jiao Tong University (Shanghai, China).
Cell line and transfection
Jurkat cells (Boster, Wuhan, China) were grown in Roswell
Park Memorial Institute-1640 medium (RPMI-1640)
(Gibco, Carlsbad, CA, USA) with 10% fetal bovine serum
(FBS) (Hyclone, Logan, UT, USA) and antibiotics at 37°C
and 5% CO2. Transient transfection was performed and
the manufacturer’s instructions were followed to use Lipo-
fectamine reagent (Invitrogen, Carlsbad, CA, USA). Typic-
ally, 5 × 106 cells/well in 6-well dishes were transfected
with 0.5 μg of plasmids. Overexpressed DQ786243 trans-
fection plasmid was purchased from SLNco (Shanghai,
China). The plasmids were grown in bacteria following the
standard techniques and purified with Qiagen Plasmid kit
(Qiagen, Hilden, Germany). Control group was transfected
with empty vector pLentiLox 3.7 (Fudan University,
Shanghai, China) followed the same instruction of transi-
ent transfection. Cells were harvested 0 hour, 24 hours
and 48 hours post transfection for further experiment.
Quantitative real-time polymerase chain reaction
(qRT-PCR)
Primers were designed with PRIMER 5.0 (ABI, Foster
City, CA, USA) and synthesized by Generay (Generay,
Shanghai, China). Total RNA from PBMCs or Jurkat
cells was extracted with TRIzol (Invitrogen, Carlsbad,isease and healthy controls
nactive CD (n = 8) CTL (n = 9) P value
31.13 ± 9.16 31.11 ± 8.82 0.999*
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RT reagent Kit (Takara Bio Inc, Shiga, Japan). The primers
for DQ786243 were: forward, 5′-TAGGCGGACATTGT
GGTGAGT-3′, and reverse 5′-CTTCTGCTGGGCTG
TTGAGTG-3′; those for CREB were: forward, 5′-GGA
GTGCCAAGGATTGAAGAAGA-3′, and reverse 5′-TG
CTGTGCGAATCTGGTATGTT-3′; those for Foxp3 were:
forward 5′-AGAAGCAGCGGACACTCAATG-3′, reverse
5’-GACTCAGGTTGTGGCGGATG-3′. Reverse transcrip-
tion was performed at 37°C for 15 minutes and at 85°C
for 5 seconds using the PrimeScript RT reagent kit (Takara
Bio Inc, Shiga, Japan) following the manufacturer’s proto-
col. PCRs were performed 5 min at 95°C, followed by 45
cycles of 15 s at 95°C, and 1 min at 60°C. The processed
were conducted on a Realtime Thermo Cycler (FTC2000,
Funglyn, Canada) with SYBR Premix Ex Taq kit (TaKaRa
Bio Inc., Shiga, Japan). The specificity of real-time PCR was
confirmed by melting-curve analysis. Relative expressions
were determined by normalizing expression of each target
to GAPDH. Data were analyzed by 2-ΔΔCt method [25].
Western blot
Cytoplasmic protein was extracted from Jurkat cells at
48 hours after transfection using nucleic/plasma protein
extraction kit (Viagene, Tampa, FL, USA). Cytoplasmic
protein is separated by SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE) after quantitation. Samples are
separated in SDS-PAGE for 1 hour respectively (Bio-rad,
Hercules, CA, USA) and transferred onto a polyvinylidene
fluoride membranes at 4°C. The membrane is blocked for
1 hour at room temperature in 5% non-fat dried milk, and
then incubated with the primary antibody with continuous
gentle agitation overnight at 4°C. Polyclonal rabbit anti-
CREB and polyclonal rabbit anti-Foxp3 were purchased
from Boster (Boster, Wuhan, China). Anti-phospho-CREB
rabbit antibody p-CREB-1 (Ser-133) was purchased from
Santa Cruz (Dallas, Texas, USA). Then the membranes
are incubated for 1 hour with HRP-conjugated secondary
anti-rabbit antibodies (Boster, Wuhan, China) at room
temperature, and finally developed by SuperSignal West
Pico Chemiluminescent Sub-strate (Pierce Biotechnology,
Rockford, IL, USA).
Statistics
GraphPad Prism 5.0 for Windows (GraphPad Software,
San Diego CA, USA) was used in statistics. P < 0.05 was
considered significant with ANOVA analysis, t-test and
linear regression.
Results
Characteristics of included subjects
19 patients and 9 healthy controls were enrolled in our
research. There were no significant age and BMI differ-
ences among three groups. One patient had a history ofsmoking. Montreal classification of extent and behavior
of CD [24] were showed (Table 1).
RNA levels of DQ786243, CREB and Foxp3 in PBMC from
patients
Quantitative RT-PCR showed that DQ786243 was sig-
nificantly overexpressed in clinical active CD patients
(ANOVA, P = 0.004) compared with clinical inactive CD
patients (t-test, P = 0.012) or healthy controls (t-test, P =
0.002). And there were no significant differences be-
tween inactive CD and controls (See Figure 1A). CREB
was also more highly expressed in active CD (ANOVA,
P = 0.005) than in inactive CD (t-test, P = 0.003) or con-
trols (t-test, P = 0.024). No significant differences were
found between inactive CD and controls (See Figure 1B).
Foxp3 was interestingly lower in inactive CD (ANOVA,
P = 0.027) compared to that in active CD (t-test, P =
0.032) or controls (t-test, P = 0.010), but there were no
significant differences between active CD and controls
(See Figure 1C).
The relationship of RNA levels and clinical inflammation
serological markers
It showed that C-reactive protein (CRP) was well corre-
lated with DQ786243 (r = 0.489, P = 0.034), CREB (r =
0.500, P = 0.029) and Foxp3 (r = 0.546, P = 0.016) (See
Figure 2A, B and C). Erythrocyte sedimentation rate
(ESR) was also related with the activity of the disease,
but no such phenomenon was found (See Figure 2D,
E and F). The expression of DQ786243 was correlated
with CREB (r = 0.552, P = 0.002) and Foxp3 (r = 0.435,
P = 0.021) at a significant level, but there was no sig-
nificant correlation between CREB and Foxp3 (See
Figure 2G, H and I).
CREB and Foxp3 expression after DQ786243 transfection
As DQ786243 was correlated the expression of CREB
and Foxp3, DQ786243 transient transfection was done
in Jurkat cells to see their relations. At 48 hours after
DQ786243 transfection, qRT-PCR showed DQ786243
was significantly increased (P = 0.005) and both CREB
(P = 0.017) and Foxp3 (P = 0.046) had an increased
mRNA expression in Jurkat cells at a significant level
(See Figure 3A). Western blot showed the same situ-
ation (See Figure 3B). Phosphorylation western blot
showed after DQ786243 transfection, the CREB phosphor-
ylation ratio (p-CREB/t-CREB) was increased at 24 hours
and 48 hours after transfection (ANOVA, P = 0.0043,
See Figure 3C).
Discussion
Tregs are an important subpopulation of T lymphocytes.
They involved in many different functions in immune
processes and play crucial roles in human disease, such
Figure 1 DQ786243 was significantly overexpressed in clinical active CD patients compared with clinical inactive CD patients or
healthy controls. And there were no significant differences between inactive CD and controls (A). CREB was also more highly expressed
in active CD than in inactive CD or controls. No significant differences were found between inactive CD and controls (B). Foxp3 was
interestingly lower in inactive CD than in active CD or controls, but there were no significant differences between active CD and controls (C).
*P < 0.05, **P < 0.01.
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tolerance and resistance to autoimmune diseases. They
can down-regulate functions of innate and adaptive im-
mune cells. Immune function disorder has been demon-
strated in CD and dysfunction of Tregs may be attributed
to this situation, but what makes the irregular functions of
Tregs has not been fully understood.Figure 2 The relationship of RNA levels and clinical inflammation sero
P = 0.034), CREB (r = 0.500, P = 0.029) and Foxp3 (r = 0.546, P = 0.016) (A, B a
activity of the disease, but no such phenomenon was found (D, E and F).
P = 0.002) and Foxp3 (r = 0.435, P = 0.021) at a significant level, but there wIn our research, three genes were detected in CD pa-
tients and controls. Early researches demonstrated that
CD4+ Foxp3+ Tregs in PBMC from CD patients were de-
creased [26,27], but Foxp3 transcripts might be similar be-
tween patients and controls [26]. These indirect proofs
showed that Foxp3 could be lower expressed in CD pa-
tients than in controls. In accordance with these results,logical markers. CRP was well correlated with DQ786243 (r = 0.489,
nd C). Erythrocyte sedimentation (ESR) was also related with the
The expression of DQ786243 was correlated with CREB (r = 0.552,
as no significant correlation between CREB and Foxp3 (G, H and I).
Figure 3 CREB and Foxp3 expression after DQ786243 transfection. At 48 hours after DQ786243 transfection, qRT-PCR showed DQ786243
was significantly increased and both CREB and Foxp3 had an increased mRNA expression in Jurkat cells at a significant level (A). Western
blot showed the same situation (B). Phosphorylation western blot showed after DQ786243 transfection, the CREB phosphorylation ratio
(p-CREB/t-CREB) was increased at 24 hours and 48 hours after transfection (C).
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expression in CD patients than in controls. In inactive CD
samples, the down-regulation of Foxp3 was found. Not
like Foxp3, CREB was found up-regulated in PBMCs from
CD patients [28]. It was the same as what we found. Actu-
ally, there were no close relationship between the expres-
sion of Foxp3 and CREB. They might work in different
pathways or with other mechanisms, such as phosphoryl-
ation. DQ786243, a new lncRNA, could play a critical role
in regulating these two genes. It was recently found
overexpressed in hepatocellular carcinoma (HCC) [14].
In our study, it was up-regulated in both active and in-
active CD patients. DQ786243 was strongly correlated
with both Foxp3 and CREB. All the three mRNAs were
correlated with CRP, an important serum marker of in-
flammation. Another indication – ESR was not. This
suggested that DQ786243 could contribute towards de-
velopment of CD. Malfunction of DQ786243 in CD pa-
tient could not be excluded.
We are very curious about how these genes work, but
there is no ready-made answer. It is commonly known
that transcription factors NFAT, AP1, Sp1, STAT5,
Smad3 and CREB-ATF have binding sites on Foxp3 en-
hancer and promoter [29]. In these transcription factors,
CREB works as a part in the enhancer 2 of Foxp3. Someevidences have shown that CREB is critical in Treg gen-
eration and maintenance based on TGF-β signaling and
T cell receptor (TCR) activation. CREB phosphorylation
is activated by TCR activation [30]. Treg-specific
demethylated region (TSDR) in Foxp3 locus contains a
CREB-activating transcription factor site overlapping a
CpG island. The CpG island is found demethylated in
Tregs but not in other T cells [15,31-33].
We also wonder the role that lncRNA can play. LncRNA
can regulate gene expression via transcription factors. In
bladder carcinoma cells, CREB level was significantly
down-regulated after knocking down of lncRNA UCA1
[34]. UCA1 alteration paralleled to the expression and
phosphorylation of CREB [34]. CREB is not always regu-
lated by lncRNA. At some time, CREB can regulate
lncRNA as well. Wang et al. found that lncRNA HULC
could be regulated by CREB [35]. MicroRNA (miRNA) -
372 was involved in the up-regulating process. A report
showed that lncRNA Tmevpg1 expression contributed to
drive Th1-dependent INF-γ expression, but maybe not
alone [36]. IFN-γ is critically required in induction of
Foxp3 and converts CD4+ CD25- T cells to Tregs [37].
LncRNA could regulate gene expression at different levels,
including chromatin modification, transcription and post-
transcriptional processing [7].
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related with CREB levels. In Jurkat cell study, DQ786243
transfection could up-regulate CREB and CREB phosphor-
ylation ratio. CREB plays a critical role in lncRNA regula-
tion. The CREB levels are not so closely related with Foxp3
levels in blood study suggests no direct relationship be-
tween CREB expression and Foxp3 level. CREB itself seems
not the mediator of DQ786243 to up-regulate Foxp3. The
phosphorylation of CREB might play a more important role
in the process. Although phosphorylation of CREB can be
regulated by DQ786243, further observation is still re-
quired. We found that DQ786243 could positively affect
the expression of Foxp3. Demethylation of TSDR might
join the DQ786243 regulating process and need further re-
search to confirm.
Conclusion
DQ786243 can be related with severity of CD. It can
affect the expression of CREB and Foxp3 through which
regulates the function of Treg. CREB itself seems not
the mediator of DQ786243 to up-regulate Foxp3. The
phosphorylation of CREB might play a more important
role in the process.
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